PwC has been named as a Leader in the IDC MarketScape: Worldwide Life Sciences Healthcare Provider (HCP) Engagement Services 2025 Vendor Assessment (September 2025, IDC #US51813524).
Commenting on PwC’s strengths, the report states that, ‘PwC combines broad life sciences industry expertise, a multidisciplinary talent pool, and strong technology innovation capabilities to support the end-to-end transformation of life sciences organizations’ HCP engagement strategies.’
It also states that, ‘PwC’s deep understanding of industry trends, strong technology expertise, and robust change management capabilities position it as a trusted partner for life sciences organizations seeking to drive innovation and future-proof their HCP engagement strategies for sustainable impact.’
IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of technology suppliers can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
“We are proud to be recognised as a Leader in this IDC MarketScape. At PwC, we see beyond today’s healthcare challenges and help our clients to see tomorrow’s solutions. We help them to build scalable capabilities and operating models to harness the potential of technologies, including GenAI, to add value to their digital health from strategy to execution. We reveal opportunities and take on any problems with bold approaches. We combine specialised expertise—in healthcare, finance, organisational transformation and technology—with innovative tools to tackle challenges. From workforce shortages and operational inefficiencies to cost pressures and patient data, we work alongside our clients to create strategic advantages.”